Origin, a national provider of pelvic floor physical therapy and women’s musculoskeletal care, said it has secured Series B funding to expand access to pelvic health services through a hybrid model combining virtual care with in-person clinics.
The round was led by SJF Ventures, with participation from Blue Venture Fund and Gratitude Railroad. The company also said it received financing from the California Infrastructure and Economic Development Bank and backing from angel investors, including Modern Fertility founder Afton Vechery, wellness entrepreneur Hannah Bronfman, and Spring Fertility founder Peter Klatsky.
Origin is positioning pelvic floor physical therapy as a mainstream, first-line option for common but frequently underdiagnosed conditions, such as incontinence, prolapse, and pain, citing the scale of unmet need among women and the high cost and fragmentation that have historically limited access to specialized care.
The company said it offers insurance-covered care across the U.S. via nationwide virtual visits and 19 physical clinics across seven states, supported by a digital platform that provides customized exercise programming and educational resources between sessions. Origin reported that nine in 10 patients see improvement in pelvic floor symptoms.
Origin said it has treated more than 50,000 patients since launching in 2020 and has insurance partnerships covering 50 million lives, with 95% of care delivered in-network and most patients paying less than $36 out of pocket per visit. The company also highlighted faster appointment access compared with hospital-based care and said its Austin and San Francisco clinics have each treated nearly 1% of women in those cities.
The company said the new funding will support continued scaling of its care model and further investment in technology, including Athena, an AI-driven clinical decision product built on longitudinal data from 39 million patient interactions over more than a decade. Origin said it has been an OpenAI partner since 2023 and is accelerating development of personalized care journeys using AI tools, including a patient-facing AI agent called GinaGPT, alongside its recently launched app, The Origin Way.
Origin also pointed to clinician supply constraints as a key limiter in the category, saying it will continue investing in training through Origin University, which trained more than 100 physical therapists and physical therapist assistants in 2025, more than double the prior year.
SJF Ventures said the financing thesis centers on Origin’s hybrid delivery model and the expansion of insurance-covered pelvic floor therapy, framing the opportunity as both outcomes-driven and large-scale, with Origin citing a $61 billion market opportunity.
KEY QUOTES
“Pelvic floor physical therapy is the standard of care. The data is clear: this effective, non-invasive therapy is the first line of treatment for dozens of women’s health issues, from postpartum recovery to incontinence. Origin’s specialized pelvic and musculoskeletal care has helped tens of thousands of patients reclaim their health, their confidence, and their quality of life. We’ve shifted pelvic floor therapy from niche to norm. This new round of funding will enable us to move it from norm to non-negotiable.”
Carine Carmy, Co-founder and CEO at Origin
“For too long, pelvic floor conditions were overlooked or ignored. Women seeking treatment had few care options, most of whom were not in network, and pelvic floor physical therapy was seen as ‘niche’ and thus underappreciated and underutilized by referring providers. Research and outcomes data demonstrates the efficacy of pelvic floor physical therapy.”
“Origin, via its hybrid in-person and virtual business model, is delivering life-changing care — and seizing a $61 billion market opportunity — by making proven solutions to pelvic floor symptoms accessible to women across all 50 states and all stages of life and medical conditions.”
Perry Clarkson, Managing Director at SJF Ventures
